MedTrace Logo

Prednisolone in Active Ankylosing Spondylitis (AS)

NCT00244166 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2006-09-11

No results posted yet for this study

Summary

1. to investigate whether steroids are effective in ankylosing spondylitis
2. if steroids are effective to describe how quick they work

Conditions

Interventions

DRUG

prednisolone

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Joachim Sieper, Prof. · Charité Campus Benjamin-Franklin Rheumatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Completion
2008-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00244166 on ClinicalTrials.gov